Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Palbociclib/ribociclib

Gastrointestinal toxicities and neutropenia: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Guerini AE, et al. A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients. Scientific Reports 10: 13589, No. 1, 12 Aug 2020. Available from: URL: http://doi.org/10.1038/s41598-020-70430-2 Guerini AE, et al. A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients. Scientific Reports 10: 13589, No. 1, 12 Aug 2020. Available from: URL: http://​doi.​org/​10.​1038/​s41598-020-70430-2
Metadaten
Titel
Palbociclib/ribociclib
Gastrointestinal toxicities and neutropenia: 7 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-90086-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Zoledronic acid